The potential use of the PEMF device to treats knee osteoarthritis

knee osteoarthritis

A clinical study evaluating the potential use of the PEMF device treats knee osteoarthritis. The Joint Preservation Centre of the Rubin Institute of Advanced Orthopaedics at Sinai Hospital. Took part in the clinical research work with N.V. Ortho fix International. To evaluate the effectiveness and safety of pulsed electromagnetic field (PEMF) technology to treat knee osteoarthritis (OA).

Their study will evaluate the potential use of PEMF devices. In reducing knee joint inflammation, reducing cartilage rupture, stimulating new cartilage formation, and reducing the need for surgery. The device sends pulses of low-level electromagnetic energy to the target area. Researchers are studying whether this can activate and enhance the body’s natural healing process.

“Millions of people are living in the pain of osteoarthritis, which may force them to restrict their activities. We are interested in seeing whether PEMF devices worn on the outside of the knee may change the disease. Relieve symptoms and provide people with invasive treatments. Option,” said Ronald Delanois, MD, principal investigator and department director of the Joint Protection and Replacement Centre at Sinai Hospital.

Knee osteoarthritis

Study participants must have diagnosed at least 40 years old. With mild-to-moderate knee osteoarthritis. Participants will wear the device on their knees for three hours a day, 7 days a week, throughout the year. No continuous use required. Follow-up appointments will schedule for 3, 6, and 12 months.

The Rubin Institute of Advanced Orthopaedics is one of three centres taking part in a double-blind randomised study. Other facilities include the Brown University School of Medicine in Providence, Rhode Island, and the Cleveland Clinic in Cleveland, Ohio. These centres are seeking to recruit 150 participants to test PEMF devices. As part of the randomisation, two-thirds of the participants will receive active treatment, and the third will receive placebo treatment.

ALSO READ: Non-invasive, drug-free PEMF therapy can help improve the destructive effects of arthritis

Osteoarthritis is a degenerative joint disease that causes cartilage. (a rubbery protein substance that acts as a cushion or cushion between the ends of bones). To break or deteriorate. It affects weight-bearing joints, including knees, hips, neck, thumbs, big toes, and spine. Symptoms may include joint pain, stiffness and swelling, and limited range of motion.

Leave a comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.